AIAI Group Corporation

6557.T · Healthcare · Medical Care Facilities · Valued as of 2026-11-03 · Statements 2026-03-31

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

What it is worth

EPV + Growth

168.70M USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

117.66M USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

55.93M USD

15 years of cash for shareholders and lenders, less what is owed

Average Intrinsic Value

114.10M USD

The plain average of EPV, Profit and FCFF

Against the price

Market Cap

25.94M USD

the price on the date above times the shares

Intrinsic Value ÷ Market Cap

4.40×

the ratio the screener ranks by

Margin of Safety

+77.3%

1 − Market Cap / Average Intrinsic Value

Projections, not exact values. Intrinsic Values are projected from each company's past reports. They show which stocks look cheap compared with the others, not exactly what a stock is worth.

Earnings power value plus growth: 168.70M USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).
①EPV (earnings power value)190.09M USD
−②Net Debt Today96.66M USD
+③Growth Value75.27M USD
=Value168.70M USD

EPV of the Operations (NOPAT over WACC)

190.09M USD

Net debt today

-96.66M USD

Growth Value

+75.27M USD

Value

168.70M USD

①EPV (earnings power value)

190.09M USD

②Net Debt Today

96.66M USD

③Growth Value

75.27M USD

Market value

Market Cap25.94M USD

The price on the date above times the shares.

Value vs market

Margin of Safety+84.6%

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): 117.66M USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.
①Present Value of the 15 Years of FCFE69.07M USD
+②Equity at Year 15, Today48.59M USD
=Value117.66M USD
FCFE: the net income left for the shareholders once the business keeps what next year's growth needsEquity reinvestment: the part of the year's net income kept in the business to grow the next year; below zero, capital the business releases to the shareholdersPresent value of the FCFEColoured bars show the FCFE, grey bars the equity reinvestment. With a positive equity reinvestment the two stacked are the year's normalized income; with a negative one the grey is below zero, capital the business releases, and the normalized income is the FCFE plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROE on new investment falling to the cost of equity. Axes linear.

①Present Value of the 15 Years of FCFE

69.07M USD

②Equity at Year 15, Today

48.59M USD

Market value

Market Cap25.94M USD

The price on the date above times the shares.

Value vs market

Margin of Safety+77.9%

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): 55.93M USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).
①Present Value of the 15 Years of FCFF31.90M USD
+②Invested Capital at Year 15, Today120.70M USD
−③Net Debt Today96.66M USD
=Value55.93M USD
FCFF: the NOPAT left for the shareholders and the lenders once the business reinvests what next year's growth needsReinvestment: the part of the year's NOPAT put back into the business to grow the next year; below zero, capital the business releasesPresent value of the FCFFColoured bars show the FCFF, grey bars the reinvestment. With a positive reinvestment the two stacked are the year's NOPAT; with a negative one the grey is below zero, capital the business releases, and the NOPAT is the FCFF plus that negative amount. Shaded, years 6 to 10: the growth rising to its long-run rate and the ROIC on new investment falling to the WACC. Axes linear.

①Present Value of the 15 Years of FCFF

31.90M USD

②Invested Capital at Year 15, Today

120.70M USD

③Net Debt Today

96.66M USD

Market value

Market Cap25.94M USD

The price on the date above times the shares.

Value vs market

Margin of Safety+53.6%

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 1.58%
Cost of Equity =Risk-Free Rate 4.50%+Beta 0.49×Market Risk Premium 6.00%= 7.47%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC =Tax Provision 1.59M USDPretax Income 5.48M USD= 28.95%

The tax the interest saves.

Interest Expense =EBIT 6.06M USD−Pretax Income 5.48M USD= 577.84K USD

The interest the company paid: EBIT is the profit before tax plus the interest.

Cost of Debt =Interest Expense 577.84K USDTotal Debt 122.37M USD×(1 − Tax Rate for WACC 28.95%)= 0.34%

What the lenders are paid a year after the tax the interest saves.

Debt Weight =Total Debt 122.37M USDMarket Cap + Total Debt 25.94M USD + 122.37M USD= 82.51%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 17.49%×Cost of Equity 7.47%+Debt Weight 82.51%×Cost of Debt 0.34%= 1.58%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2026-03-31.

Total Assets 168.50M USD − Total Liabilities 148.17M USD = Book Value Today 20.33M USD

Total Debt 122.37M USD − Cash and Short-Term Investments 25.71M USD = Net Debt Today 96.66M USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 14.6%at most 5%passes6,482,136 / 6,195,996
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets1.1%at least -10.0%passes(5.67M USD − 3.89M USD) ÷ 168.50M USD
Price to bookMarket Cap ÷ Book Value Today1.28×at most 3×passes25.94M USD ÷ 20.33M USD
Operating marginOperating Income ÷ Revenue7.6%above 10.0%does not pass6.92M USD ÷ 91.64M USD
Revenue growthRevenue ÷ Revenue a Year Before − 14.8%above 10.0%does not pass91.64M USD / 87.45M USD
Net cash(Cash − Total Debt) ÷ Market Cap-372.6%above -30%does not pass(25.71M USD − 122.37M USD) ÷ 25.94M USD
Operating efficiencyOperating Income ÷ Gross Profit39.7%above 25.0%passes6.92M USD ÷ 17.45M USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Share price

627.63 JPY

Enterprise value

18.54B JPY

the provider's own figure

EV / EBITDA

9.67×

Price / book

1.17×

the provider's book

Price / earnings

6.12×

Return on equity

20.3%

the provider's figure, not this page's

Profit margin

3.8%

Revenue growth

85.5%

Analyst target, mean

—

Analysts

—

opinions in the consensus

Financial Statements

The annual lines the screener holds, year by year, in USD at each period's rate; the figures this valuation read are in its calculation above.

USD2023202420252026
Income statement

Revenue

81.33M78.12M87.45M91.64M

Gross profit

10.12M11.47M14.31M17.45M

Operating income

606.55K3.52M4.91M6.92M

EBITDA

operating income before depreciation and amortisation

4.89M8.67M9.02M10.31M

Pretax income

-1.69M3.39M3.81M5.48M

Net income

-3.80M2.33M2.82M3.89M

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

-122.30K3.99M4.33M4.16M

R&D

————
Balance sheet, year end

Total assets

88.25M77.05M83.45M168.50M

Total liabilities

78.17M65.52M64.59M148.17M

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

10.08M11.54M18.85M20.33M

Total debt

65.24M51.96M47.87M122.37M

Cash and equivalents

9.82M11.03M15.70M25.71M

Net PP&E

fixed assets after depreciation

58.33M48.50M43.74M58.95M

Working capital

current assets less current liabilities

10.14M4.97M5.15M-12.84M
Cash flow

Operating cash flow

6.57M11.68M9.33M5.67M

Capital expenditure

paid out, so below zero

-6.68M-3.80M-2.37M-2.01M

Depreciation and amortisation

6.00M4.83M4.75M4.25M

Free cash flow

operating cash flow plus capital expenditure

-113.72K7.88M6.95M3.66M